| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/04/2002 | CA2423955A1 Kini-3 motor protein and methods for its use |
| 04/04/2002 | CA2423953A1 Hydrolases |
| 04/04/2002 | CA2423919A1 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | CA2423889A1 Methods and compositions for screening modulators of lipid kinases |
| 04/04/2002 | CA2423708A1 Method for producing human anti-thymocyte immunoglobulins |
| 04/04/2002 | CA2423704A1 G-protein coupled receptors |
| 04/04/2002 | CA2423701A1 Oxidoreductases |
| 04/04/2002 | CA2423694A1 Transferases |
| 04/04/2002 | CA2423668A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 04/04/2002 | CA2423613A1 Transgenic drosophilia melanogaster expressing beta amyloid |
| 04/04/2002 | CA2423483A1 Taxoid conjugates as antimitotic and antitumor agents |
| 04/04/2002 | CA2423482A1 Fluorinated quinolones as antimitotic and antitumor agents |
| 04/04/2002 | CA2423434A1 Lactone integrin antagonists |
| 04/04/2002 | CA2423424A1 Secreted proteins |
| 04/04/2002 | CA2423305A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | CA2422530A1 Human drug metabolizing enzymes |
| 04/04/2002 | CA2421851A1 Tgf-.beta. inhibitors and methods |
| 04/04/2002 | CA2421209A1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
| 04/04/2002 | CA2420577A1 Peptide-based compounds |
| 04/04/2002 | CA2420475A1 Ige receptor antagonists |
| 04/03/2002 | EP1193268A1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
| 04/03/2002 | EP1193267A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein JunKinases |
| 04/03/2002 | EP1193257A2 Compounds for ceramide-mediated signal transduction |
| 04/03/2002 | EP1193250A1 Phenyl sulfamate derivatives |
| 04/03/2002 | EP1193249A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 04/03/2002 | EP1193246A1 Aminobenzoic acid derivatives |
| 04/03/2002 | EP1192951A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 04/03/2002 | EP1192950A1 Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as the active ingredient |
| 04/03/2002 | EP1192949A1 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient |
| 04/03/2002 | EP1192945A2 Use of an estrogen agonist/antagonist for treating osteoarthritis |
| 04/03/2002 | EP1192450A1 High energy phototherapeutic agents |
| 04/03/2002 | EP1192281A2 Use of ras inhibitors for inhibiting muscle atrophy |
| 04/03/2002 | EP1192278A1 48 human secreted proteins |
| 04/03/2002 | EP1192271A1 Antisense modulation of interleukin-5 signal transduction |
| 04/03/2002 | EP1192266A2 Complement-resistant non-mammalian dna viruses and uses thereof |
| 04/03/2002 | EP1192261A1 22025, a novel human cyclic nucleotide phosphodiesterase |
| 04/03/2002 | EP1192251A1 Human sel-10 polypeptides and polynucleotides that encode them |
| 04/03/2002 | EP1192248A1 Antisense modulation of ship-2 expression |
| 04/03/2002 | EP1192247A1 Sphingosine kinase enzyme |
| 04/03/2002 | EP1192177A1 Statine-derived tetrapeptide inhibitors of beta-secretase |
| 04/03/2002 | EP1192174A2 Antagonists of bmp and tgf beta signalling pathways |
| 04/03/2002 | EP1192170A1 Propargyl phenyl ether a2a receptor agonists |
| 04/03/2002 | EP1192165A2 Substituted heterocycle fused gamma-carbolines |
| 04/03/2002 | EP1192164A1 Thieno- and furopyrimidine derivatives as a2a-receptor antagonists |
| 04/03/2002 | EP1192160A1 1-azatricyclic-4-benzylpiperazines |
| 04/03/2002 | EP1192158A2 Substituted 8-phenylxanthines useful as antagonists of a 2b? adenosine receptors |
| 04/03/2002 | EP1192152A1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof |
| 04/03/2002 | EP1192151A1 Anilinoquinazolines as protein tyrosine kinase inhibitors |
| 04/03/2002 | EP1192150A1 New pharmaceutically active compounds |
| 04/03/2002 | EP1192146A1 Chroman derivatives resisting neurological disorders |
| 04/03/2002 | EP1192144A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids |
| 04/03/2002 | EP1192141A1 1,4-diazacycloheptane derivatives as neuroprotective agents |
| 04/03/2002 | EP1192136A2 Oligomers and polymers of cyclic imino carboxylic acids |
| 04/03/2002 | EP1192133A1 N-cyclopentyl modulators of chemokine receptor activity |
| 04/03/2002 | EP1192132A2 Serine protease inhibitors |
| 04/03/2002 | EP1192131A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives |
| 04/03/2002 | EP1192129A2 Pharmaceutical compounds |
| 04/03/2002 | EP1192128A1 Thiol derivative, metallo-beta-lactamase inhibitors |
| 04/03/2002 | EP1192127A1 Substituted benzamide inhibitors of rhinovirus 3c protease |
| 04/03/2002 | EP1192125A2 Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 04/03/2002 | EP1192122A1 Benzene derivatives, preparation method and pharmaceutical compositions containing same |
| 04/03/2002 | EP1191948A2 High dose radionuclide complexes for bone marrow suppression |
| 04/03/2002 | EP1191945A1 Methods and compositions for control of bone formation via modulation of leptin activity |
| 04/03/2002 | EP1191942A2 Treatment of endometriosis with antileukoprotease |
| 04/03/2002 | EP1191941A1 A method for the prophylaxis and/or treatment of medical disorders |
| 04/03/2002 | EP1191934A1 Il-8 receptor antagonists |
| 04/03/2002 | EP1191931A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 04/03/2002 | EP1162201A9 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
| 04/03/2002 | EP1007512B1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors |
| 04/03/2002 | EP0988312B1 17beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis |
| 04/03/2002 | EP0986574B1 11beta-aryl substituted 14,17-ethano-oestratriens, method for the production of these compounds and their use in the production of medicaments. |
| 04/03/2002 | EP0931087B1 Novel pyranoside derivatives |
| 04/03/2002 | EP0898567B1 N-aminoalkyl-1-biphenylenyl-2-carboxamides; dopamine receptor subtype specific ligands |
| 04/03/2002 | EP0874645B1 Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics |
| 04/03/2002 | EP0873331B1 Benzofuran carboxamides and sulphonamides |
| 04/03/2002 | EP0865440B1 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
| 04/03/2002 | EP0809512B1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin |
| 04/03/2002 | EP0775199B1 Superoxide dismutase-4 |
| 04/03/2002 | CN1343221A Polypeptide variants with altered effector function |
| 04/03/2002 | CN1343217A New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 04/03/2002 | CN1343212A Derivatives of monosaccharides as well adhesion inhibitors |
| 04/03/2002 | CN1343206A Cyclocompound |
| 04/03/2002 | CN1343205A Dimeric compounds and as inhibitors of neuraminidase |
| 04/03/2002 | CN1343197A Biphenyl derivatives as antagonists of neurokinine-1 receptor |
| 04/03/2002 | CN1343185A Vital matter and producing method thereof |
| 04/03/2002 | CN1343174A 计量阀 Metering valve |
| 04/03/2002 | CN1343129A Sustained release salts of pharmaceutically active peptides are their production |
| 04/03/2002 | CN1343127A Potentiation of anti-CD38-immunotoxin cytotoxicity |
| 04/03/2002 | CN1343122A Remedies for joint diseases |
| 04/03/2002 | CN1342495A Mucosal immunovaccine |
| 04/03/2002 | CN1342479A Quick-acting oral liquid for treating sprain and pull and its preparing process |
| 04/03/2002 | CN1342455A Liniment for preventing pig bite |
| 04/03/2002 | CN1081924C Pharmaceutical composition comprising plant worms and muirapuama |
| 04/03/2002 | CN1081923C Chitosan and use of polysaccharide fixed on it in producing hard tissue irritant |
| 04/02/2002 | USRE37623 Enzyme inhibitors, their synthesis, and methods for use |
| 04/02/2002 | US6365749 Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 04/02/2002 | US6365714 Amino acid sequence of a polypeptide; antiinflammatory agents; antiproliferative agents; antiapoptotic agents |
| 04/02/2002 | US6365630 Compositions and methods for inhibiting photoaging of skin |
| 04/02/2002 | US6365628 Fatty analogues for the treatment of diabetes |
| 04/02/2002 | US6365627 Method for treating a patient with neoplasia by treatment with a paclitaxel derivative |